News & Analysis on Clinical Trial Services & Contract Research And Development
Dutch chemicals and excipients distributor Univar has hooked up with US manufacturer Innophos to provide the EU pharmaceutical market with its entire portfolio of excipients, helping to fill the gap left by the departure of Rhodia from the phosphate...
US drug discovery firm BioProcessors has unveiled a new range of cell culture services to assist in biopharmaceutical process development.
German researchers have shown 3D cell structures better resemble tumour phenotypes than traditional cultures, suggesting they will make better models for testing new anticancer agents.
Parexel has purchased a clinical research organisation (CRO) in Taiwan as a means to exert its presence in this industry's budding Asia-Pacific region.
Sales of laboratory products in Germany have recovered from a 'stagnant period' between 2001 and 2004 to reach a record €5.3bn in 2006.
Denmark-based Bavarian Nordic has received an advance payment of $50m (€35.4m) from the US Government for meeting milestones in one of its smallpox vaccine supply contracts.
UK-based TeraView has had its tablet imaging technology backed by the US Food and Drug Administration (FDA), following a study by the regulatory agency.
GlaxoSmithKline (GSK) thinks that drugs based on boron, rather than carbon, could side-step the issue of resistance in anti-bacterial and anti-viral therapy - and is willing to bet billions on it.
Rumours that Pfizer is looking into buying a large stake in Sanofi-Aventis, which could be seen as a prelude to a full takeover bid, has prompted a flurry of shareholder activity.